Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
Gastroenterology ; 137(4): 1229-37; quiz 1518-9, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19549528

ABSTRACT

BACKGROUND & AIMS: Endoscopist-directed propofol sedation (EDP) remains controversial. We sought to update the safety experience of EDP and estimate the cost of using anesthesia specialists for endoscopic sedation. METHODS: We reviewed all published work using EDP. We contacted all endoscopists performing EDP for endoscopy that we were aware of to obtain their safety experience. These complications were available in all patients: endotracheal intubations, permanent neurologic injuries, and death. RESULTS: A total of 646,080 (223,656 published and 422,424 unpublished) EDP cases were identified. Endotracheal intubations, permanent neurologic injuries, and deaths were 11, 0, and 4, respectively. Deaths occurred in 2 patients with pancreatic cancer, a severely handicapped patient with mental retardation, and a patient with severe cardiomyopathy. The overall number of cases requiring mask ventilation was 489 (0.1%) of 569,220 cases with data available. For sites specifying mask ventilation risk by procedure type, 185 (0.1%) of 185,245 patients and 20 (0.01%) of 142,863 patients required mask ventilation during their esophagogastroduodenoscopy or colonoscopy, respectively (P < .001). The estimated cost per life-year saved to substitute anesthesia specialists in these cases, assuming they would have prevented all deaths, was $5.3 million. CONCLUSIONS: EDP thus far has a lower mortality rate than that in published data on endoscopist-delivered benzodiazepines and opioids and a comparable rate to that in published data on general anesthesia by anesthesiologists. In the cases described here, use of anesthesia specialists to deliver propofol would have had high costs relative to any potential benefit.


Subject(s)
Anesthesia , Anesthetics, Intravenous/adverse effects , Endoscopy , Propofol/administration & dosage , Anesthesia/adverse effects , Anesthesia/economics , Anesthetics, Intravenous/administration & dosage , Anesthetics, Intravenous/economics , Clinical Competence , Consumer Product Safety , Cost-Benefit Analysis , Endoscopy/economics , Global Health , Health Care Costs , Humans , Intubation, Intratracheal , Masks , Practice Guidelines as Topic , Propofol/adverse effects , Propofol/economics , Respiration, Artificial/instrumentation , Risk Assessment
2.
Nat Rev Gastroenterol Hepatol ; 6(5): 279-86, 2009 May.
Article in English | MEDLINE | ID: mdl-19404268

ABSTRACT

The success and accuracy of colonoscopy is largely dependent on appropriate cleansing of the colon. The ideal bowel preparation should be safe, well-tolerated and effective. Although colonoscopy preparations are vastly better than the earliest barium enemas used in X-ray regimens, none of the currently available formulations sufficiently fulfills the above criteria. Currently used techniques of colon cleansing include dietary and cathartic methods, gut lavage and the administration of phosphates. All of these methods are efficacious, particularly when administered in a split dose (one the evening before and one just before the planned colonoscopy). Gut lavage methods are the safest method; however, dietary and cathartic methods are also reasonably safe. Low-dose phosphate preparations are well tolerated, but safety concerns have led to the withdrawal of some phosphate products from the US market. A new oral sulfate product that achieves a desirable balance of safety, tolerability in patients and efficacy will shortly be introduced. Physicians should be aware of the range of colonoscopy preparations available and their limitations, so that the best preparation can be chosen for an individual patient.


Subject(s)
Colonic Diseases/diagnosis , Colonoscopy/methods , Humans
3.
Middle East J Anaesthesiol ; 18(6): 1171-84, 2006 Oct.
Article in English | MEDLINE | ID: mdl-17263273

ABSTRACT

Ehlers-Danlos syndrome is an inherited disorder that results in dysfunctional collagen bundles. These dysfunctional collagen bundles are most noticeable in tissues rich with collagen fibers--skin, vessels, GI, and ligaments. Until gene therapy advancements can correct the underlying gene mutations causing faulty collagen, the mainstay of treatment is prevention of traumatic injury. The success of anesthetic management in patients with EDS requires and understanding of the role of collagen in the various tissues of the body. Collagen-rich tissue fragility, skin hyperextensibility, joint hypermobility, hematoma formation and cardiovascular disease are just some of the complications that need to be accounted for before every anesthetic procedure involving EDS patients. Anesthesiologists should be keenly that any physical manipulation of EDS patients incurs risks of trauma.


Subject(s)
Anesthesia/methods , Ehlers-Danlos Syndrome , Intraoperative Complications/prevention & control , Postoperative Complications/prevention & control , Anesthesia/adverse effects , Ehlers-Danlos Syndrome/genetics , Ehlers-Danlos Syndrome/physiopathology , Ehlers-Danlos Syndrome/therapy , Humans , Perioperative Care/methods
SELECTION OF CITATIONS
SEARCH DETAIL